Acquisitions (Tables)

12 Months Ended

Dec. 31, 2019

The following summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition for all acquisitions consummated during the years ended December 31 ($ in millions):



	2019			2018			2017
Accounts receivable	$	46.4		$	86.7		$	103.7
Inventories	189.9			3.9			37.3
Property, plant and equipment	56.4			7.1			137.1
Goodwill	2,192.9			1,601.2			1,035.2
Other intangible assets, primarily customer relationships, trade names and technology	1,651.8			1,345.8			587.8
Trade accounts payable	—			(9.9		)	(18.7		)
Other assets and liabilities, net	(243.6		)	(219.7		)	(289.0		)
Previously held investment	—			—			(36.8		)
Prepaid acquisition asset related to Non-Principal Countries	50.1			—			—
Net cash consideration	$	3,943.9		$	2,815.1		$	1,556.6

The following summarizes the estimated fair values of the assets acquired and liabilities assumed as of December 31, 2019 for ASP in 2019, and all of the other 2019 acquisitions as a group ($ in millions):



	ASP			Other			Total
Accounts receivable	$	—		$	46.4		$	46.4
Inventories	173.8			16.1			189.9
Property, plant and equipment	45.7			10.7			56.4
Goodwill	1,420.3			772.6			2,192.9
Other intangible assets, primarily customer relationships, trade names and technology	1,120.0			531.8			1,651.8
Other assets and liabilities, net	(73.4		)	(170.2		)	(243.6		)
Prepaid acquisition asset related to Non-Principal Countries	50.1			—			50.1
Net cash consideration	$	2,736.5		$	1,207.4		$	3,943.9

The following table summarizes the provisional fair value estimates of the assets acquired and liabilities assumed of Principal and Non-Principal Countries that have been transferred to ASP as of December 31, 2019; we did not acquire accounts receivable or accounts payable from Johnson & Johnson ($ in millions):



	Advanced Sterilization Products
Inventories	$	173.8
Property, plant and equipment	45.7
Goodwill	1,420.3
Other intangible assets, primarily customer relationships, trade names and technology	1,120.0
Other assets and liabilities, net	(73.4		)
Total consideration allocated to closed Principal and Non-Principal Countries	2,686.4
Prepaid acquisition asset related to remaining Non-Principal Countries	50.1
Net cash consideration	$	2,736.5

Pro Forma Information

The pro forma information is presented for informational purposes only and is not necessarily indicative of the results of operations that actually would have been achieved had the acquisitions been consummated as of that time ($ in millions except per share amounts):



	2019		2018
Sales	$	7,659.9	$	7,625.3
Net earnings from continuing operations	$	805.0	$	898.7
Diluted net earnings per share from continuing operations	$	2.37	$	2.56